1. Home
  2. LAB vs SLP Comparison

LAB vs SLP Comparison

Compare LAB & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.83

Market Cap

326.2M

Sector

Industrials

ML Signal

HOLD

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$18.34

Market Cap

370.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAB
SLP
Founded
1999
1996
Country
United States
United States
Employees
389
213
Industry
Biotechnology: Laboratory Analytical Instruments
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
326.2M
370.7M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
LAB
SLP
Price
$0.83
$18.34
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$1.35
$24.00
AVG Volume (30 Days)
4.5M
577.8K
Earning Date
05-05-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
61.54
N/A
EPS
0.33
0.43
Revenue
$101,937,000.00
$59,577,000.00
Revenue This Year
N/A
$3.80
Revenue Next Year
$2.63
$5.90
P/E Ratio
$2.65
$42.63
Revenue Growth
N/A
10.52
52 Week Low
$0.70
$11.09
52 Week High
$1.72
$21.01

Technical Indicators

Market Signals
Indicator
LAB
SLP
Relative Strength Index (RSI) 47.73 65.07
Support Level $0.79 $17.74
Resistance Level $1.01 $18.57
Average True Range (ATR) 0.07 0.09
MACD 0.00 -0.09
Stochastic Oscillator 30.41 64.58

Price Performance

Historical Comparison
LAB
SLP

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: